1Evans RW, Crawley JB, Garratt RC, Grossmann JG, et al. Characterization and structural analysis of a functional human serum transferrin variant and implications for receptor recognition[J]. Biochemistry, 1994,Oct 18;33(41): 12512.
2Musial J, Undas A, Gajewski P, et al. Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia[J]. Int J Cardiol, 2001,77 (2-3): 247-253.
4Biasucci LM, Liuzzo G, Buffon A, et al. The variable role of inflammation in acute coronary syndromes and in restenosis[J]. Semin Interv Cardiol, 1999,4(3): 105-110.
5Yu H, Rifai N. High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy[J]. Clin Biochem,2000,33(8) :601-610.
6Horne BD, Muhlestein JB, Carlquist JF, et al. Statin therapy,lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease[J]. J Am Coll Cardiol,2000,36(6): 1774-1780.
7Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells [J]. Circulation, 2000,102 (18): 2165-2168.
8Versaci F, Gaspardone A, Tomai F, et al. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation[J]. Am J Cardiol,2000,85(1) :92-95,A8.
9Biasucci LM, Liuzzo G, Angiolillo DJ, et al. Inflammation and acute coronary syndromes [J]. Herz, 2000, 25(2) :108-112.
10Rifai N, Ridker PM. High-sensitivity C-reactive protein:a novel and promising marker of coronary heart disease[J].Clin Chem,2001,47(3) :403-411.
